Volume 8, Number 8—August 2002
Research
Antecedent Treatment with Different Antibiotic Agents as a Risk Factor for Vancomycin-Resistant Enterococcus
Yehuda Carmeli*†
, George M. Eliopoulos*†, and Matthew H. Samore*†
, George M. Eliopoulos*†, and Matthew H. Samore*†Table 2
Multivariable explanatory model for having vancomycin-resistant enterococci-positive case
| Variable | Odds ratio (95% CI) | p value |
|---|---|---|
| Main admitting disorder | 0.44 (0.28 to 0.68) | <0.001 |
| Cardiovascular | 2.9 (1.5 to 5.7) | 0.002 |
| Infectious | ||
| Coexisting conditions | ||
| Diabetes mellitus | 2.1 (1.5 to 3.1) | <0.001 |
| Transplant recipient | 2.6 (1.6 to 4.5) | <0.001 |
| Hepatobiliary disease | 2.9 (1.8 to 4.6) | <0.001 |
| MRSA (in past yr) Clostridium difficile (in past yr) | 3.5 (1.8 to 6.9) 2.0 (0.97 to 4.3) | <0.001 0.06 |
CI, confidence interval; MRSA, methicillin-resistant Staphylococcus aureus.
